CVS Health Corporation stockholders approved the 2026 Incentive Compensation Plan and the ratification of Ernst & Young LLP as the company's independent auditor at the 2026 Annual Meeting. A stockholder proposal to reduce the threshold for the right to act by written consent was defeated, receiving 417,969,177 votes in favor and 617,361,014 votes against.
